Nexalin Technology (NXL) Receivables - Net (2021 - 2026)
Nexalin Technology's (NXL) quarterly Receivables - Net came in at $43004.0 in Q1 2026, up 197.01% year-on-year from $14479.0 in Q1 2025, and down 47.28% quarter-over-quarter from $81571.0 in Q4 2025.
Nexalin Technology (NXL) Receivables - Net (2021 - 2026) Analysis & Trends
Nexalin Technology's Receivables - Net history runs 6 years deep, the most recent figure standing at $43004.0 for Q1 2026.
- On a quarterly basis, Receivables - Net rose 197.01% year-over-year to $43004.0 in Q1 2026; TTM through Mar 2026 was $43004.0, a 197.01% increase from a year earlier, with the FY2025 full-year figure at $81571.0, up 525.4% from the prior year.
- Receivables - Net fell to $43004.0 in Q1 2026 per NXL's latest filing, from $81571.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $81571.0 in Q4 2025 and bottomed at $3550.0 in Q1 2023.
- The 5-year median for Receivables - Net is $13043.0 (2024), against an average of $20491.4.
- Across the five-year window, Receivables - Net tumbled 70.1% in 2022 and surged 525.4% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $4875.0 in 2022, then surged by 92.18% to $9369.0 in 2023, then surged by 39.21% to $13043.0 in 2024, then jumped by 525.4% to $81571.0 in 2025, then sank by 47.28% to $43004.0 in 2026.
- Per Business Quant, the three latest NXL Receivables - Net figures stand at $43004.0 (Q1 2026), $81571.0 (Q4 2025), and $7925.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,004.00 |
| Mar 31, 2026 | 43,004.00 |
| Dec 31, 2025 | 81,571.00 |
| Dec 31, 2025 | 81,571.00 |
| Sep 30, 2025 | 7,925.00 |
| Sep 30, 2025 | 7,925.00 |
| Jun 30, 2025 | 59,841.00 |
| Jun 30, 2025 | 59,841.00 |
| Mar 31, 2025 | 14,479.00 |
| Mar 31, 2025 | 14,479.00 |
| Dec 31, 2024 | 13,043.00 |
| Dec 31, 2024 | 13,043.00 |
| Sep 30, 2024 | 15,171.00 |
| Sep 30, 2024 | 15,171.00 |
| Jun 30, 2024 | 11,720.00 |
| Jun 30, 2024 | 11,720.00 |
| Mar 31, 2024 | 3,666.00 |
| Mar 31, 2024 | 3,666.00 |
| Dec 31, 2023 | 9,369.00 |
| Dec 31, 2023 | 9,369.00 |